It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Introduction Spain went into lockdown in March of 2020 due to the COVID-19 outbreak. We had to stop the third randomization of our ongoing clinical trial (Mediavilla et al., 2019), pausing weekly group psychotherapy for 12 people with a first episode of psychosis. Only 5 weekly sessions had been delivered, thus many were just starting to form a therapeutic link with the group. In a public health emergency context, psychotherapeutic groups are considered avoidable gatherings. However, stopping psychological therapy abruptly can make participants more vulnerable. The intervention groups were launched in an online format because we could not let anyone go without psychological support in such a difficult time. Objectives Communicate how we adapted an ongoing clinical trial to an online format during the lockdown in Spain. Methods In light of our participants’ needs and their acute deterioration the first two weeks of lockdown, we adapted our intervention. First, both arms (mindfulness-based v. psychoeducational multicomponent intervention) began online adaptations of the interventions. Second, a research assistant made weekly phone calls to provide basic psychosocial support, assure participants groups would continue, and later remind them of each online session. Third and last, the phoneline was accessible 24/7 (WhatsApp). Results The third randomization concluded in December. Six participants were lost in the transition to online groups. However, adherence was comparable to the previous two randomizations (4/12 completed the intervention). Conclusions Online psychotherapy may be used in emergencies such as a lockdown. However, the psychological mid- and long-term effects of a lockdown and online group therapy remain unknown. Disclosure No significant relationships.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Hospital La Paz Institute for Health Research (IdiPAZ), Psychiatry And Mental Health, Madrid, Spain; Autonomous University of Madrid, Department Of Psychiatry, Madrid, Spain
2 Hospital La Paz Institute for Health Research (IdiPAZ), Psychiatry And Mental Health, Madrid, Spain; Autonomous University of Madrid, Department Of Psychiatry, Madrid, Spain; Centro de Investigación Biomédica en Red de Salud Mental, Cibersam, Madrid, Spain
3 Hospital La Paz Institute for Health Research (IdiPAZ), Psychiatry And Mental Health, Madrid, Spain; Autonomous University of Madrid, Department Of Psychiatry, Madrid, Spain; La Paz University Hospital, Psychiatry, Clinical Psychology And Mental Health, Madrid, Spain
4 Hospital La Paz Institute for Health Research (IdiPAZ), Psychiatry And Mental Health, Madrid, Spain; Autonomous University of Madrid, Department Of Psychiatry, Madrid, Spain; Centro de Investigación Biomédica en Red de Salud Mental, Cibersam, Madrid, Spain; La Paz University Hospital, Psychiatry, Clinical Psychology And Mental Health, Madrid, Spain